Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 13 Results

Title
Intervention Indication Therapeutic Area Year Actions
Durvalumab with or without tremelimumab in addition to platinum based chemotherapy for extensive-stage disease small-cell lung cancer Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) , Tremelimumab (CP-675206; CP-675 206) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2019 View  |  Download
Durvalumab for limited stage small-cell lung cancer after
1 therapy
Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2022 View  |  Download
Atezolizumab in addition to chemotherapy for small cell lung cancer – first line Atezolizumab (Tecentriq; MPDL3280A) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2018 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications